Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Autoimmune Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT03886753
What this trial is testing

Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products

Who this might be right for
ALSAutism Spectrum DisorderCancer+15 more
Children's Hospital of Philadelphia 10
Testing effectiveness (Phase 2)UnknownNCT00569101
What this trial is testing

A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus Nephritis

Who this might be right for
Lupus Nephritis
Seoul National University Hospital 9
Not applicableEnrolling By InvitationNCT07517536
What this trial is testing

CHT105 for the Treatment of Refractory Lupus Nephritis

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 14
Testing effectiveness (Phase 2)Study completedNCT04893096
What this trial is testing

MOR202 for Refractory MN

Who this might be right for
Membranous Nephropathy
Mario Negri Institute for Pharmacological Research 10
Early research (Phase 1)Looking for participantsNCT06710717
What this trial is testing

Autologous CD19 Car T-Cell Therapy For Severe Refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematous (SLE)
National University of Malaysia 5
Early research (Phase 1)Looking for participantsNCT06371040
What this trial is testing

Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Ting Chang, MD 9
Not applicableLooking for participantsNCT05988216
What this trial is testing

Universal CAR-T Cells (BRL-301) in Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Bioray Laboratories 12
Testing effectiveness (Phase 2)Study completedNCT00392951
What this trial is testing

Sirolimus for Autoimmune Disease of Blood Cells

Who this might be right for
Autoimmune PancytopeniaAutoimmune Lymphoproliferative Syndrome (ALPS)Evans Syndrome+6 more
Children's Hospital of Philadelphia 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07738822
What this trial is testing

A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHA

Who this might be right for
Immune Thrombocytopenia (ITP)Warm Autoimmune Hemolytic Anemia (WAIHA)
Cullinan Therapeutics Inc. 72
Testing effectiveness (Phase 2)UnknownNCT05020288
What this trial is testing

A Clinical Trial of the Orelabrutinib in the Management of Refractory ITP

Who this might be right for
Immune ThrombocytopeniaBruton's Tyrosine Kinase
Shandong University 40
Large-scale testing (Phase 3)Study completedNCT02301624
What this trial is testing

Extension Study of ECU-MG-301 to Evaluate Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis

Who this might be right for
Refractory Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 117
Not applicableLooking for participantsNCT07154524
What this trial is testing

Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
University of Ulm 140
Early research (Phase 1)WithdrawnNCT06377228
What this trial is testing

TAK-007 in Adults With Refractory Lupus Nephritis (LN) or Refractory Systemic Sclerosis (SSc)

Who this might be right for
Refractory Lupus NephritisRefractory Systemic Sclerosis
Takeda
Early research (Phase 1)Not Yet RecruitingNCT07676266
What this trial is testing

C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy

Who this might be right for
Multiple Sclerosis (MS)Myasthenia Gravis (MG)Neuromyelitis Optica Spectrum Disorder+3 more
The Affiliated Hospital of Qingdao University 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07659704
What this trial is testing

CD19-Directed CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
University of Sao Paulo 16
Early research (Phase 1)Looking for participantsNCT06980597
What this trial is testing

OL-108 in Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Idiopathic Inflammatory Myopathy (IIM)Systemic Sclerosis (SSc)+1 more
Beijing GoBroad Hospital 44
Early research (Phase 1)Looking for participantsNCT06978647
What this trial is testing

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Inflammatory Myopathy+5 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 12
Early research (Phase 1)Active Not RecruitingNCT06255028
What this trial is testing

CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisIdiopathic Inflammatory Myopathies+1 more
Century Therapeutics, Inc. 6
Very early researchUnknownNCT06417398
What this trial is testing

Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusIdiopathic Inflammatory MyopathiesSystemic Sclerosis+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Not applicableNot Yet RecruitingNCT07811622
What this trial is testing

Clinical Study of CHT105 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Immune Thrombocytopenia (ITP)
Nanjing Miracle Biotechnology Co., Ltd. 24
Next Page